The Nuclear Medicine Point of View in Orthopaedic Infections: Imaging with Tc-99m-Ciprofloxacin, Infecton
Tc-99m radiolabelled ciprofloxacin, which we call Infecton, was first described by the radiopharmacist K. Solanki, who noted that the effectiveness of ciprofloxacin diminishes when taken with iron. He postulated that this was because of chelation of the iron with the antibiotic. He, therefore, prophesied that he could chelate technetium-99m to the antibiotic and this would lead to technetium-99m-ciprofloxacin.
KeywordsArthritis Tuberculosis Gall Staphylococcus Argentina
Unable to display preview. Download preview PDF.
- Amaral H, Morales B, Pruzzo, Britton KE (1999) Cold-hot mismatch between Tc-99mhexamethyl propyleneamine oxime (HMPAO)-labelled leukocytes and Tc-99m Ciprofloxacin in actual skeleton infections. A report of three cases. Clin Nucl Med 24: 855–858Google Scholar
- Britton KE, Padhy AK (2000) Nuclear Imaging for Infection and Inflammation, Co-ordinated research project, E1–30. 14. Final report, IAEA, Vienna, pp 1–152Google Scholar
- Hall AV, Solanki KK, Vinjamuri S, Britton KE, Das SS (1998) Evaluation of the Efficacy of 99m-Tc-Infecton. A novel agent for detecting sites of infection. J Clin Pathol 51: 215–219Google Scholar
- Larikka M, Ahonen A, Onni N, et al (2002a) Comparison of 99m-Tc-Ciprofloxacin-(Infecton), 99mTc White-blood cell and 3 phase bone imaging in the diagnosis of hip prosthesis infections: Improved diagnostic accuracy with extended imaging time. Nucl Med Commun 23: 655–661Google Scholar
- Larikka MJ, Ahonen AK, Niemela O, et al (2002b) 99m Tc-Ciprofloxacin ( Infecton) imaging in the diagnosis of knee prosthesis infections. Nucl Med Commun 23: 167–170Google Scholar
- Soroa VE, Cabrejas RC, Alonso O, Solanki KK, Britton KE (2001) Five years experience with ciprofloxacin-Tc-99m ( Infecton) in the bone-infected patient. Eur J Nucl Med 28: 12–16Google Scholar